Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|March 19, 2004
[Tuberculosis--current news about the "white pestilence" in the year 2004]Dieter UkenaDeutsches Arzteblatt International|July 24, 2009
Bronchial asthma: diagnosis and long-term treatment in adultsDieter Ukena, Liat Fishman, Wilhelm-Bernhard NieblingZentralblatt Fur Chirurgie|January 9, 2019
[Surgical Therapy for Lung Cancer: Why it Should be Performed in High Volume Centres]Hans Hoffmann, Bernward Passlick, Dieter Ukena, et al.The Annals of Thoracic Surgery|January 23, 2003
Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopyThomas P Graeter, Dirk Hellwig, Klaus Hoffmann, et al.The Journal of Thoracic and Cardiovascular Surgery|December 2, 2004
Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinomaDirk Hellwig, Thomas P Graeter, Dieter Ukena, et al.Pulmonary Pharmacology & Therapeutics|September 12, 2006
Ciclesonide is more effective than budesonide in the treatment of persistent asthmaDieter Ukena, Christian Biberger, Volker Steinijans, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2007
18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?Dirk Hellwig, Thomas P Graeter, Dieter Ukena, et al.Molecular Imaging and Biology|October 11, 2003
2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography in target volume definition for radiotherapy of patients with non-small-cell lung cancerUrsula Nestle, Dirk Hellwig, Sylvia Schmidt, et al.Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|October 25, 2006
[National Disease Management Guideline for Asthma: recommendations and evidence for "asthma prevention" issues]Dietrich Berdel, Roland Buhl, Rainer Dierkesmann, et al.Clinical Lung Cancer|April 28, 2006
Multicenter randomized trial for stage IIIB/IV non-small-cell lung cancer using every-3-week versus weekly paclitaxel/carboplatinWolfgang Schuette, Thomas Blankenburg, Wolf Guschall, et al.Pageof 2